Discussion points on Bill S-5

Similar documents
The Voice of Local Public Health in New York State. May 12, 2014

A combination of licensed medication and professional support is four times more likely to achieve a stop in smoking behaviour.

MARKETING STANDARDS FOR MEMBERSHIP

Claims about health in ads for e-cigarettes. CAP and BCAP s regulatory statement

Policy Options for the Regulation of Electronic Cigarettes

Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill. Japan Tobacco International (JTI)

How to Regulate E-Cigarettes? Are we asking the right questions?

Electronic/E-cigarettes. In summary

Electronic Nicotine and Non Nicotine Delivery Systems (ENDS)

REGULATORY OPTIONS FOR MOVING TO THE ELIMINATION OF SMOKING. Ron Borland PhD

E-cigarettes: Evidence, perceptions and misconceptions. Martin Dockrell, Tobacco Control Programme Lead

Texas Bill to Regulate Vapor Products. Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes

Bill. amending the Tobacco Control Act, No. 6/2002, with subsequent amendments. From the Minister of Health.

ESPs are battery-operated devices that contain cartridges filled with liquid chemicals. The chemicals turn into a vapour that the user inhales (this

E-Cigarettes: A Game Changer. Dr. Blake Brown Hugh C. Kiger Professor Agriculture and Resource Economics College of Agriculture & Life Sciences

The New Zealand experience with electronic cigarettes

Policy Options for the Regulation of Electronic Cigarettes

Introduction. Principles

Towards a Smokefree Generation: A Tobacco Control Plan for England. Tim Baxter, Department of Health, England

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis

Problem Which option Additional option Additional comments definition Yes No change No further observations.

E-cigarettes. Threat or opportunity?

Executive Summary. No Fire, No Smoke: The Global State of Tobacco Harm Reduction 2018

E-Cigs, Etc.: Policy Options for Regulating Nicotine Delivery Devices. Indiana Local Boards of Health Webinar Feb. 12, 2015

The Tobacco and Vaping Products Act: Implications for E-Cigarette Point-of-Sale Promotion

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018

Electronic cigarettes: A new era for tobacco harm reduction Adapted for SW Specialist Nurses for Children in Care meeting 17 January 2017

OCSA HEALTH CANADA NOTICE OF INTENT - Vape Products

Use of e-cigarettes (vapourisers) among adults in Great Britain

American Vaping Association

Electronic Cigarettes: What we know so far

Improving the regulatory framework for electronic cigarettes (e-cigarettes) and emerging tobacco and nicotine-delivery products

Non-Industry Voices on Tobacco Harm Reduction and Vaping Products

Guideline for Advertising of e-cigarettes

Consultation on Electronic Cigarettes. Analysis of submissions

Cannabis Legalization and Regulation in British Columbia Discussion Paper

The Independent British Vape Trade Association (IBVTA) welcomes the opportunity to respond to this consultation.

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

15 Electronic Cigarettes Update

OMA Submission on Health Canada s Proposed Regulations for Additional Cannabis Products. February 2019

E.cigarettes. An alternative to a uniquely deadly product that kills one in two of its regular users? Paul Lambert Public Health, Leeds City Council

Welcome to the wild, wild west.

Consultation on legislation for the sale of tobacco products and non-medicinal nicotine delivery system, including e-cigarettes

Policy Options for the Regulation of Electronic Cigarettes

The Latest on Vaping Among U.S. Teens

Evaluating Interventions to Curb ENDS Use Among Utah Youth

Chapter 9 TOBACCO AND SYNTHETIC NICOTINE CONTROL

MDQuit Best Practices Conference January 26, Presented by William C. Tilburg Deputy Director

SENATE, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED JANUARY 30, 2014

Tobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products

WHO Framework Convention on Tobacco Control

The Benefits and Regulations of Electronic Cigarettes

E-cigarette reforms. Supplement to the Tobacco retailer guide about reforms commencing 1 August 2017

How to think AND feel about nicotine and the people who use it

Melodie Tilson, Director of Policy

Coach on Call. Thank you for your interest in E-Cigarettes: Your Questions Answered. I hope you find this tip sheet helpful.

Prevent disease Protect from injury Promote healthy lifestyles

ASSEMBLY, No STATE OF NEW JERSEY. 213th LEGISLATURE INTRODUCED NOVEMBER 23, 2009

City of Oshawa Comments to the Provincial Government Concerning Cannabis Consumption

Key Elements of this Presentation. Smoking Still Main Cause of Premature Death 31/10/2013. The Case for Plain Packaging

Global E-Cigarette Market- Industry Analysis & Outlook ( )

DRAFT FOR CONSULTATION

REPUBLIC OF SOUTH AFRICA

Re: Policy Options for the Regulation of Electronic Cigarettes

Wayne Hall and Coral Gartner University of Queensland

My story parallels many of my own customers. I smoked for nearly 20 years, beginning in college, a combination of factors contributing to my

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association

Proposed Kitsap Public Health District Vapor Products Ordinance Responsiveness Record

Bill C-51 and Natural Health Products - The Facts

Smoke free Environments (Controls and Enforcement) Amendment Bill 28 January 2011

POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC PUBLIC CONSULTATION DOCUMENT

FDLI Annual Conference

Proposed Amendments to the Cannabis Regulations: Edible Cannabis, Cannabis Extracts and Cannabis Topicals

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016

Electronic Cigarettes and the Medical Society

Office of the Chief Medical Health Officer

E-Cigarettes and Vapes

Scottish Health Action on Alcohol Problems. Alcohol (Licensing, Public health and Criminal Justice) (Scotland) Bill

PUBLIC CONSULTATION DOCUMENT

GLOBAL TOBACCO REGULATION OVERVIEW IVAN GENOV RESEARCH ANALYST 31 MAY 2018

RESPONSE FROM ALTRIA:

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality

consistent with the industry documents we note in our September letter.

TOBACCO PLAYBOOK DÉJÀ VU: E-CIGARETTES MICHIGAN CANCER CONSORTIUM MARCH 26, 2014

Policy Options for the Regulation of Electronic Cigarettes

TOBACCO PLAYBOOK DÉJÀ VU: E-CIGARETTES

The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j))

ELEVEN REASONS WHY S IS BAD PUBLIC POLICY. Clinton Admin. FY00 budget request for FDA tobacco regulation was $34 million.

CMA Submission: Submission to the Senate Standing Committee on Social Affairs, Science and Technology

H. R. ll IN THE HOUSE OF REPRESENTATIVES A BILL

Alcohol etc. (Scotland) Bill. Chivas Brothers Ltd and Pernod Ricard

TOWNSHIP OF BRUCE MACOMB COUNTY, MICHIGAN ORDINANCE NO. 193 MINOR IN POSSESSION OF TOBACCO AND VAPOR PRODUCTS ORDINANCE TITLE.

PRO/CON: Are federal regulations needed for e-cigarettes?

Key findings from a national survey of 1,000 registered voters, conducted February 2-5, Project # 15054

Legalization of Cannabis- Overview

REDUCING YOUTH ACCESS AND APPEAL OF VAPING PRODUCTS CONSULTATION ON POTENTIAL REGULATORY MEASURES

Tobacco Data, Prevention Spending, and the Toll of Tobacco Use in North Carolina

Is Vaping a Valid Strategy for Smoking Cessation? Myths and Facts Jaspreet S. Brar. MD, PhD Community Care Behavioral Health Organization

AMA Submission House of Representatives Standing Committee on Health and Ageing inquiry into the

Cannabis Retail Store Licensing in Ontario. General Committee December 10, 2018

Transcription:

Disclaimer: The following document was developed to provide a brief set of discussion points for individuals wishing to discuss Bill S-5 with policy makers, politicians, senators or their advisers. It attempts to balance both positive and negative aspects of individual items, as well as the Bill as a whole. Please note, some of these issues are not universally accepted by supporters of vaping, and you may feel that this summary does not match your own views. This is OK! Feel free to substitute your own views and rationale where you see fit. The Argument for Vaping as Harm Reduction Tobacco smoke contains approximately 80 Harmful or Potentially Harmful Chemicals (HPHC's), which are known to cause the clear majority of harm to smokers. These include Carbon Monoxide, Formaldehyde, Ammonia, etc. With vaping, 80% of these HPHC's are absent and the HPHC's that are present in vaping devices are at substantially lower levels. Liquid used in vaping products are a mixture of 3 main components: Base ingredients (propylene glycol and vegetable glycerin), nicotine (optional) and flavouring. The base ingredients, which comprise most of the liquid, are used in numerous products, including products intended for inhalation. Vaping products are also technologies that can be improved, so any worrying levels of HPHC's can be reduced or possibly eliminated through technological improvements. For these reasons, it has been estimated that vaping is at least 95% safer than smoking, and these conclusions are supported by reviews conducted by Public Health England (PHE), The Royal College of Physicians (RCP), and many others. There are two main arguments against vaping. The first that it acts as a gateway to smoking or that it renormalizes smoking. The concern is that vaping will reverse, or at least slow down the speed at which smoking rates have been (or are expected to be) dropping. To date there is no evidence that this has occurred anywhere, and wherever vaping has been widely accessible, smoking rates, particularly among youth have been falling faster than in recent years. There is strong, population level data to suggest that fears of a gateway effect are currently unfounded, and this is supported by comprehensive reviews done by Public Health authorities in the UK, as well as in Canada with the recent UVIC report. The second argument against vaping deals with the unknowns. While we cannot be 100% confident of the long term (i.e. 20+ years) impacts of vaping to the individual, what we do know is that vaping is, at least for the short term, far safer than smoking. While this unknown aspect of vaping can seem troubling, there is nothing that has been identified that would indicate that long term use of vaping products would begin to approach the harm from long term smoking. The 95% less harmful estimate includes potential long term unknown harms in its estimate. Page 1 of 8

Vaping presents a huge opportunity as a harm reduction strategy. Health Canada can be a world leader and encourage vaping to help them reach their goals of 5% by 2035. Implicitly, this is to reduce the significant health burden that comes from smoking. As vaping is known to be substantially less harmful than smoking, one of the strategies must be to encourage adult smokers who are unable or unwilling to quit to switch to vaping. To achieve this though, the regulations pertaining to vaping need to be fit-for-purpose and not work against this goal. Regulations need to be innovative, and not subject to the same mode of thinking that was used when tobacco regulations were crafted and enacted. Bill S-5 gets it wrong, in that it would have the effect of reducing adult smokers access to vaping to address a problem that evidence shows doesn't currently exist. Additionally, overly restrictive regulations on vaping products favours only one industry: Big Tobacco. By reducing the appeal of switching from smoking to vaping, it limits tobacco companies from competition of a vastly safer product. Regulations that attempt to prohibited items favoured by the clear majority of adult vapers would also drive the market underground, where products sold would have no quality control standards. Intent of Bill S-5 The stated intent of Bill S-5 is to balance two competing interests, the need to protect youth from potential harms of vaping while allowing adults access. As an overview, the significant flaws in the way these issues are framed are as follows: Protect Children In second reading, Senator Petitclerc stated that 26% of youth have tried vaping. This ignores the fact that most youth use nicotine free vaping products, use them very infrequently or just once or twice, and that youth smoking rates are falling faster than in recent times. There is no evidence of a gateway effect occurring, which is confirmed by several expert reviews on the matter (see UVIC report, PHE Report, RCP Report, Cancer Research UK, etc.). All evidence that purports to confirm a gateway effect is based on small sample sizes or has drawn claims of causation from cross sectional studies, which is widely regarded as inappropriate. Assure Adult access to Vaping products The evidence clearly supports harm reduction potential. Any restrictions on products or promotions will reduce adult access and use. Canadians Charter rights need to be considered when restricting harm Page 2 of 8

reduction products in this way. Items in Bill S-5 I support Overall, I believe that Bill S-5 is significantly flawed and will do more to harm to the health of Canadians than to protect them. I do believe that there are sections of this Bill that, on their own, could be positive. The following are the items in Bill S-5 that I would support: 1. Ban on sales to minors I support vaping as a harm reduction product, one that should be vitally important for smokers of all ages to have access to. I also feel strongly that sales to minors should not be permitted, in much the same way that alcohol is prohibited for sales to minors. The clear majority of retailers have voluntarily prohibited sales to minors, even before many provinces formalized this requirement in regulations. Position Statement: I support prohibiting sales of vaping products to minors. 2. Provisions to undertake quality assurance testing and standards Vaping products are vastly safer than smoking; however, without quality control standards, contamination could occur in the manufacturing process. Vaping should not be viewed in the same way as tobacco cigarettes, with little opportunity for improvements. More accurately, vaping should be considered a technology, one that can be improved through improvements in flavouring and device design. Since the invention of vaping products, a rapid and continual rate of improvement has already occurred, one that has seen the safety of these products increase, through the identification and elimination of certain potentially harmful ingredients and improvements to the electronics. There is no evidence to suggest that product improvements cannot continue to be made in the foreseeable future. Some regulatory systems elsewhere (i.e. FDA) requires product testing through their pre-market authorization system that imposes overly onerous and costly burdens to manufacturers. The anticipated impact of this is to remove nearly all products and make it essentially impossible to bring new products to market. Position Statement: I support a regulatory framework that sets fair and reasonable product standards, that works to identify potential product improvements and allows industry to implement those improvements. Page 3 of 8

I do not support onerous product testing protocols that do little to improve public safety but could substantially increase the cost of bringing products to market. 3. Restrictions on lifestyle advertising Lifestyle advertising was a method that tobacco companies used in the past in Canada to promote smoking. The intended effect was to encourage non-smokers to start smoking, by making it seem appealing, even despite the gathering evidence of the significant harm it caused. I believe that the ability to promote vaping using truthful scientific claims is the most critical aspect for advertising. Position Statement: I would support restrictions on the use of lifestyle advertising, provided the ability to make truthful scientific claims or use testimonials is permitted. 4. Prohibition on youth oriented labeling, marketing and advertising. I accept that marketing and labeling that could be considered appealing to youth is not a critical component of the success of vaping as a harm reduction alternative to smoking. A strong case can be made that prohibiting sales to minors should be enough to protect youth and discourage them from experimenting with vaping products. Additionally, a compelling example can be seen in the sale of alcoholic beverages, where youth-oriented marketing is widely acceptable, despite the real harms that are experienced by underage drinking. I view this issue as a responsible consideration to ensure that vaping is seen for what it is, a harm reduction product for sale to adult smokers. Position Statement: I support prohibiting the use of youth oriented labeling, marketing and advertising. 5. Prohibition on ingredients, such as vitamins, caffeine, etc. Ingredients, such as vitamins and caffeine could be (and historically have been) used to give a product the appearance of a health benefit. The goal of this type of marketing was to encourage non-users to use these products. As the target market for vaping products is smokers, the benefits of vaping on its own should be sufficient to convince a smoker to switch to vaping. Any health benefit that is being implied through the addition of an ingredient that may be realized should be required to be subject to appropriate regulations that deal with products that make health claims. Page 4 of 8

Position Statement: I support prohibiting the use of ingredients that could be used to give the impression of health benefits. Items in Bill S-5 I oppose I am opposed to several provisions included in Bill S-5 as I strongly feel the justification for these restrictions or prohibitions has not been demonstrated. Many of the provisions included in Bill S-5 are like existing tobacco regulations, and the justification for the tobacco regulations was clear when they were introduced; to prevent youth from starting, to discourage adults from smoking and encourage smokers to quit smoking. It is irrational to believe that the types of regulations that are enacted specifically to have an intended result (i.e. to get adult smokers to not smoke), will not have the same impact on vaping. The intent of Bill S-5 is not to encourage adult smokers or vapers to not vape, yet Bill S-5 will have that very consequence, which will likely lead to only one possible outcome: more Canadian's smoking and suffering the consequences, then otherwise would have. Specifically, the following is a summary of each provision I am concerned with in Bill S-5, in no particular order: 1. Prohibition on flavours The wide variety of flavours is one of the main reasons why smokers switch to vaping. Restricting flavours will greatly impact the rate at which smokers switch to vaping. Restricting flavours will send some vapers back to smoking, as removing access to flavours they enjoy would eliminate their reason for switching to vaping in the first place. Restricting flavours will also increase the size of the black market, as adult vapers will seek out the flavours that appeal to them. Research shows that flavours are the least important aspect for youth that experiment with vaping. Position Statement: I strongly oppose any prohibition on the use of flavours in vaping products. I could endorse the restrictions on the promotion of flavours, providing there is no prohibition on the use of any flavour. 2. Prohibition on making truthful scientific claims or testimonials Over time, the public's perception on the relative health risks of vaping Page 5 of 8

vs. smoking has been decreasing, with less and less people correctly identifying that vaping is safer or significantly safer than smoking. In order to ensure Canadian adult smokers understand the advantage vaping has over smoking with regards to health risks, some means of communicating the current scientific evidence of this is required. Although I agree that claims should be accurate and truthful, regulations may be needed to clarify the overall allowable message for truthful scientific claims or testimonials, to ensure wildly inaccurate claims are prohibited. Position Statement: I do not support a blanket prohibition on the use of scientific claims and testimonials. I could support restrictions on making scientific claims and would support regulations that would allow testimonials and assure only truthful scientific claims endorsed or approved by an accredited body are permitted. 3. Restrictions on packaging, including size and quantity Restrictions on vaping liquid bottle sizes and nicotine concentrations have been introduced elsewhere (EU), purportedly to minimize harms from exposure to the liquids, particularly on the skin or through accidental drinking. These restrictions have no scientific or logical basis. Restrictions on bottle size will increase waste and increase costs. Restrictions on nicotine content will reduce the effectiveness of vaping as an alternative to smoking and as such will reduce the number of smokers that switch. Position Statement: I do not support restricting product size. I would not oppose restrictions on nicotine content, provided the limit is set at an appropriate and scientifically justifiable level 4. Fines for vapor product related infractions on par with fines set for tobacco products Vaping is widely recognized as being far safer than smoking. Health Canada acknowledges as much when it uses the phrase likely less harmful. The vaping industry is composed of numerous small and medium sized businesses, and not a small collection of multi-national companies with profit measured by the billions. Fines for tobacco products were set to penalize these large corporations, Page 6 of 8

which need to be substantial enough to ensure compliance. As essentially all vaping companies are smaller sized, with substantially smaller profit, and the harms from vaping are substantially less than from cigarettes, overly excessive fines for the vaping industry would disproportionately impact and cause significant harm to the industry. Position Statement: I do not support fines or penalties for infractions for vaping product manufacturers or retailers that are on par with similar infractions for tobacco manufacturers or retailers. I would support fines or penalties for infractions, provided they are set at levels that would be proportionate with the vast difference in health risks and business sizes. Additional Items that should be considered with Bill S-5 Apart from the items included in the current draft of Bill S-5, I believe several other issues should be considered during deliberations of this legislation. Specifically, the following is a summary of additional considerations that I would like to highlight, in no particular order: Timing with respect to Health Canada's Tobacco Control Strategy Health Canada recently initiated public consultation to help in developing a strategy for tobacco control for the next 10 years. Within this consultation, Health Canada is contemplating how vaping will fit into their approach, and if and how the harm reduction potential of vaping should be considered. This updated strategy is due to be finalized and released in March 2018. Should Health Canada move towards an endorsement of vaping as a harm reduction method, the restrictions included in Bill S-5 would conflict with this and would raise further Charter challenges. Position Statement: I recommend not moving forward with any regulations now that could potentially be in conflict with the upcoming update to Health Canada's Tobacco Control Strategy. I would continue to support regulations that would not conflict with the upcoming update to Health Canada's Tobacco Control Strategy. Provisions for a 2 year review period of the regulations Vaping is still a relatively new technology and as such scientific research and evidence is currently not comprehensive. Research into vaping is growing rapidly. Page 7 of 8

Locking in regulations for a fast-moving industry could slow innovation and restrict and reduce smokers from switching to vaping. The Minister of Health is on record as saying the science is catching up. Position Statement: I would request that a requirement be provided for regulations to be reviewed every two years to ensure the regulations are in line with the most current scientific evidence available. Page 8 of 8